Hanahan DJ: Platelet activating factor: A biologically active phosphoglyceride . Annu Rev Biochem55:483-509, 1986
2.
Needleman P. , Turk J., Jakschik BA, et al: Arachidonic acid metabolism . Annu Rev Biochem55:69-102, 1986
3.
Samuelsson B. , Dahlen S.-E, Lindgren JA, et al: Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science237:1171-1176,1987
4.
Wedmore CVWilliams TJ: Control of vascular permeability by polymorphonuclear leukocytes in inflammation . Nature289:646-650. 1981
5.
Tashjian AH Jr.Voelkel EFLazzaro M. et al: Human transforming growth factors alpha and beta stimulate prostaglandin production and bone resorption in cultured mouse calvaria. PNAS82:4535-4538, 1985
6.
Robinson DRTashjian AH Jr.Levine L.: Prostaglandin-stimulated bone resorption by rheumatoid synovia. J Exp Med150:338-350, 1979
7.
Lewis RAAusten KF: The biologically active leukotrienes: Biosynthesis. metabolism, receptors. functions, and pharmacology. J Clin Invest73:889, 1984
8.
Serafin WE, Austen KF: Mediators of immediate hypersensitivity reactions. N Engl J Med317:30-34, 1987
9.
FitzGerald GA , Brash ARFalardeau P. et al: Estimated rate of prostacyclin secretion into the circulation of normal man. J Clin Invest68:1272, 1981
10.
FitzGerald GA , Oates JA, Hawiger J., et al: Endogenous synthesis of prostacyclin and thromboxane and platelet function during chronic aspirin administration in man. J Clin Invest72:676, 1983
11.
Goodwin JS, Geuppens J.: Regulation of the immune response by prostaglandins. J Clin Immunol3:295-310, 1983
12.
Makoul GT, Robinson DR, Bhalla AK, et al: Prostaglandin E2 inhibits the activation of cloned T cell hybridomas . J Immuno134:2645-2650, 1985
13.
Simkin NJ, Jelinek DF, Lipsky PE: Inhibition of human B cell responsiveness by prostaglandin E2. J Immunol138:1074-1081, 1987
14.
Walker C., Kirstensen F., Bettens F., et al: Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. J Immunol130:1770, 1983
Rola-Pleszczysnki M.: Immunoregulation by leukotrienes and other lipoxygenase metabolites. Immunol Today6:302-307, 1985
17.
Johnson HM, Torres BA: Leukotrienes: Positive signals for regulation of γ-interferon production . J Immunol132:413-416, 1984
18.
Marshall PJ , Kulmacz RJ, Lands WEM: Constraints on prostaglandin biosynthesis in tissues. J Biol Chem262:3510-3517, 1987
19.
Ferreira SJ , Vane JR: New aspects of the mode of action of nonsteroid anti-inflammatory drugs. Annu Rev Pharmacol Toxicol14:57, 1974
20.
Davidson FF , Dennis EA, Powell M., et al: Inhibition of phospholipases A2 by "Lipocortins" and calpactins. J Biol Chem262:1698-1705, 1987
21.
Simopoulos AP, Kifer RR, Martin RE (eds): Health Effects of Polyunsaturated Fatty Acids in Seafoods. Academic Press, New York, 1986
22.
Bonta IL, Bult H., Vincent JE, et al: Acute anti-inflammatory effects of aspirin and dexamethasone in rats deprived of endogenous prostaglandin precursors. J Pharm Pharmacol29:1-7, 1977
23.
Prickett JD , Robinson DR, Steinberg AD: Effects of dietary enrichment with eicosapentaenoic acid upon autoimmune nephritis in female NZB×NZW/F1 mice. Arthritis Rheum26:133-139, 1983
24.
Robinson DR, Tateno S., Patel B. et al: The effects of dietary marine lipids on autoimmune disease. IN Proceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Eicosanoids, Lands WEM (ed). American Oil Chemists' Society, Champaign, IL, 1987, pp 139-147
25.
Prickett JD , Trentham DE, Robinson DR: Dietary fish oil augments the induction of arthritis in rats immunized with type II collagen. J Immunol132:725-729, 1984
26.
Leslie CA, Gonnerman WA, Ullman MD, et al; Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J Exp Med162:1336-1349, 1985
27.
Prickett JD , Robinson DR, Bloch KJ: Enhanced production of IgE and IgG antibodies associated with a diet enriched in eicosapentaenoic acid. Immunology46:819-826, 1982
28.
Cathcart ES, Mortensen RF, Gonnerman WA, et al: Effects of dietary fish oil in plasma and macrophage amyloid P component acute phase responses in mice. IN Proceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Eicosanoids , Lands WEM (ed). American Oil Chemists' Society, Champaign, IL, 1987, pp 104-108
29.
Lee TH, Mencia-Huerta J-M., Shih C., et al: Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotrienes B5 and the double lipoxygenase product. J Biol Chem259:2383, 1984
30.
Terano T., Salmon JA, Moncada S.: Biosynthesis and biologic activity of leukotriene B5. Prostaglandins27:217, 1984
31.
Kremer JM, Jubiz W., Michalek A., et al: Fish-oil fatty acid supplementation in active rheumatoid arthritis . Ann Intern Med106:497, 1987
32.
Lee TH, Hoover RL, Williams JD, et al: Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med312:1217-1224, 1985
33.
Sperling RI , Weinblatt M., Robin J-L., et al: Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum30:988-997, 1987
34.
Moore GF, Yarboro C., Sebring NG, et al: Eicosapentaenoic acid (EPA) in the treatment of systemic lupus erythematosus (SLE). Arthritis Rheum30(suppl):S33, 1987
